Phase 4 N=203 Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
Hypercholesterolemia
Primary: LDL-C Lowering Efficacy — -51; -41 Percent Change from Baseline — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=413 Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)
Chronic Lung Disease
Primary: Number and Percentage of Participants With Immune Reactivity — 0; 1; 1; 0.0 Participants
Phase 4 N=266 Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Glaucoma · Ocular Hypertension
Primary: Intraocular Pressure (IOP) — 17; 17.5 mm Hg — p=0.024